GN Corporation Co Ltd, collaborating with JBM Inc., and Edogawa Hospital, have succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D tissue engineering platform.
For more details, please refer to the article published in The Knee.
GN Corporation Co Ltd, collaborating with JBM Inc., and Edogawa Hospital, have succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D tissue engineering platform.
For more details, please refer to the article published in The Knee.
The first report of Beta glucan food supplements y…
Our 3D-TGP platform based method cultures chondroc…
GN Corporation Co Ltd, collaborating with JBM Inc….
A paper describing the potentials of Nichi Glucan …
Please visit the site https://www.japan.go.jp/econ…
A study of nitiglucan on children with autism has …
A breakthrough achievement published in Life Scien…
Spinning a solution in healthcare from a basic tec…